The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The GLP-1 Payment Demonstration is bringing affordable weight loss medication to Medicare Part D beneficiaries.

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

In a spirited conversation, "Shark Tank" star Cuban and Medicare director Chris Klomp discussed the future of health care in the U.S.

List includes medications for diabetes, cancer, arthritis, and more ...

Stop worrying about high deductibles and surprise pharmacy bills during your retirement.

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug ...

Tuesday afternoon, the House of Representatives voted in favor of a spending bill that includes major pharmacy benefit manager (PBM) reforms aimed at increasing price transparency for consumers and ...

Negotiations Will Occur in 2026 With Negotiated Prices Effective in 2028.8, 2026 - On Tuesday, the Centers for Medicare & ...